ThermoGenesis Holdings, Inc.

The momentum for this stock is not very good. ThermoGenesis Holdings, Inc. has good growth characteristics. ThermoGenesis Holdings, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in ThermoGenesis Holdings, Inc..

News

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Sees Large Growth in Short Interest

Zolmax ThermoGenesis Holdings, Inc. (NASDAQ:THMO - Get Free Report) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 35,100 shares, an...\n more…

Why ThermoGenesis (THMO) Shares Are Down 40%

Benzinga ThermoGenesis Holdings shares are trading lower by 41% during Wednesday's session. The Nasdaq denied the company's request for continued listing.\n more…

Why Is ThermoGenesis (THMO) Stock Down 37% Today?

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nThermoGenesis stock is down on Wednesday after the company notified investors of a potential delisting of THMO shares next week.\nThe...\n more…

Short Interest in ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Drops By 26.3%

Ticker Report ThermoGenesis Holdings, Inc. (NASDAQ:THMO - Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 21,300 shares, a drop of...\n more…

THMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nTHMO stock results show that ThermoGenesis Holdings missed analyst estimates for earnings per share and missed on revenue for the first...\n more…

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.56 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.74 per share a year ago. These figures are adjusted...\n more…